Pedia BP®: Leveraging Technology for Early Screening of Pediatric Blood Pressure Measurements

With the increased incidence of pediatric hypertension, global blood pressure (BP) surveillance can identify strategies for early blood pressure screenings. Pedia BP® smartphone technology, an app-based screening tool, was used in 45 countries from 2017 to 2022. Data from 843 children aged 3 to 18 was analyzed. Children aged 3 to 5 years experienced more Stage 1 and 2 hypertension than children aged 6 to 18 years. Race and gender did not correlate with the hypertension stage; however, socioeconomic status may have been a contributory factor. Pedia BP interprets blood pressure based on clinical screening guidelines and supports early interventions, such as school-based policies.